Tirzepatides additional GIP receptor activity makes it distinct from Trulicity and may contribute to its enhanced effects on weight loss and metabolic health
Unfortunately, this is not always possible
Alcohol consumption decisions while taking retatrutide should be made in consultation with your healthcare provider who understands your complete medical history, current medications, and individual risk factors
For weight management, Wegovy is licensed for adults with a body mass index (BMI) of 30 kg/m or greater, or 27 kg/m or greater with at least one weight-related comorbidity (such as hypertension, dyslipidaemia, or obstructive sleep apnoea)
These custom formulations aren't FDA-approved and are not available in all states
J Am Acad Dermatol 2007;56:901-16